Insider · CIK 0001662119

Amado Rafael

CIK 0001662119 Name as filed on the most recent filing

Filed as Amado Rafael (25)

25 transaction lines · from 25 filings · filed 2019-01-16 to 2026-04-08 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

25 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-26 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-04-06 S, Open-market sale Zai Lab LtdZLAB 56,007, disposed Open Form 4 filing 0000905148-26-001603
2026-04-02 S, Open-market sale Zai Lab LtdZLAB 202,065, disposed Open Form 4 filing 0000905148-26-001542
2026-03-13 S, Open-market sale Zai Lab LtdZLAB 55,083, disposed Open Form 4 filing 0000905148-26-001283
2026-03-03 S, Open-market sale Zai Lab LtdZLAB 173,800, disposed Open Form 4 filing 0000905148-26-001174
2025-12-31 S, Open-market sale Zai Lab LtdZLAB 188,039, disposed Open Form 4 filing 0000905148-26-000003
2025-08-08 S, Open-market sale Zai Lab LtdZLAB 105,000, disposed Open Form 4 filing 0000905148-25-002836
2025-04-04 S, Open-market sale Zai Lab LtdZLAB 100,284, disposed Open Form 4 filing 0000905148-25-001113
2025-04-02 S, Open-market sale Zai Lab LtdZLAB 270,677, disposed Open Form 4 filing 0000905148-25-001078
2025-03-17 S, Open-market sale Zai Lab LtdZLAB 115,230, disposed Open Form 4 filing 0000905148-25-000969
2024-12-31 S, Open-market sale Zai Lab LtdZLAB 199,289, disposed Open Form 4 filing 0000905148-25-000011
2024-08-12 S, Open-market sale Zai Lab LtdZLAB 50,463, disposed Open Form 4 filing 0000905148-24-002230
2024-04-04 S, Open-market sale Zai Lab LtdZLAB 30,594, disposed Open Form 4 filing 0000905148-24-001109
2024-03-15 S, Open-market sale Zai Lab LtdZLAB 47,980, disposed Open Form 4 filing 0000905148-24-000977
2024-01-02 S, Open-market sale Zai Lab LtdZLAB 509,169, disposed Open Form 4 filing 0000905148-24-000063
2022-08-02 S, Open-market sale Allogene Therapeutics, Inc.ALLO 23,940, disposed Open Form 4 filing 0001737287-22-000057
2022-07-05 S, Open-market sale Allogene Therapeutics, Inc.ALLO 22,880, disposed Open Form 4 filing 0001662119-22-000002
2022-06-21 S, Open-market sale Allogene Therapeutics, Inc.ALLO 22,360, disposed Open Form 4 filing 0001214659-22-008241
2022-05-19 S, Open-market sale Allogene Therapeutics, Inc.ALLO 85,092, disposed Open Form 4 filing 0001214659-22-007226
2022-03-15 S, Open-market sale Allogene Therapeutics, Inc.ALLO 39,848, disposed Open Form 4 filing 0001214659-22-004087
2021-10-01 S, Open-market sale Allogene Therapeutics, Inc.ALLO 280,185, disposed Open Form 4 filing 0001214659-21-010210
2021-03-15 S, Open-market sale Allogene Therapeutics, Inc.ALLO 106,471, disposed Open Form 4 filing 0001214659-21-003241
2020-10-07 S, Open-market sale Allogene Therapeutics, Inc.ALLO 651,515, disposed Open Form 4 filing 0001214659-20-008508
2020-10-01 S, Open-market sale Allogene Therapeutics, Inc.ALLO 354,662, disposed Open Form 4 filing 0001214659-20-008375
2019-08-06 S, Open-market sale Adaptimmune Therapeutics PLCADAP 22,749, disposed Open Form 4 filing 0001104659-19-044630
2019-01-14 S, Open-market sale Adaptimmune Therapeutics PLCADAP 16,259, disposed Open Form 4 filing 0001104659-19-002164

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 25
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Amado Rafael, insider transactions. Retrieved 2026-08-26 from https://ebomi.com/insider/0001662119

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.